Overview

Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the 1 month safety and tolerability after multiple oral doses of AZD1656 in patients with Type 2 Diabetes Mellitus Treated with Metformin

Phase:

Phase 2

Details

Lead Sponsor:

AstraZeneca

Treatments:

Metformin